In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | S-1 |
Net revenue | 38.0 | 31.3 | 23.6 | 21.0 |
Net revenue growth | 21.4% | 32.9% | 12.0% | |
Operating costs and expenses: | | | | |
Cost of revenue | | | | 5.8 |
Research and development | | | | 10.2 |
Selling, general and administrative | | | | 64.7 |
Intangible amortization | | | | 3.7 |
Total operating costs and expenses | | | | 359.4 |
Loss from operations | 3.9 | -141.0 | -59.9 | -138.7 |
Operating margin | 10.3% | -450.2% | -254.2% | -659.4% |
|
Other (income) expense: | | | | |
Loss on foreign currency exchange | | | | 0.2 |
Loss before income taxes | -23.4 | -88.4 | -47.6 | -178.6 |
Income tax expense | 0.0 | 0.0 | -0.1 | 0.0 |
Net loss | -23.4 | -88.4 | -47.5 | -178.6 |
|
Earnings Per Share [Abstract] | | | | |
Net loss per share attributable to common stockholders - basic | ($0.17) | ($0.67) | ($0.36) | ($0.95) |
Net loss per share attributable to common stockholders - diluted | ($0.17) | ($0.67) | ($0.36) | ($0.95) |
|
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | | | | |
Weighted average number of shares during the period-basic | 134.2 | 0.1 | 0.1 | 187.5 |
Weighted average number of shares during the period -diluted | 134.2 | 132.9 | 132.9 | 187.5 |